Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Interleukin-4-Conjugated Exotoxin Active Against Biliary Tract Carcinoma
Link ID 12508
Title Interleukin-4-Conjugated Exotoxin Active Against Biliary Tract Carcinoma
Url http://www.medscape.com/viewarticle/586834?src=rss
Description An interleukin-4 (IL-4)-conjugated Pseudomonas exotoxin (IL-4-PE) is active against human biliary tract carcinoma, according to a report in the December 15th issue of the International Journal of Cancer. Reuters Health Information
Category Articles > Pathology and Lab Medicine
Keywords
Date Jan 16, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pathology and Lab Medicine
1. Single PSA Test Before Age 50 Predicts Long-Term Risk
  The long-term risk for prostate cancer can be predicted with a 1-time prostate-specific antigen (PSA) test before 50 years of age. Medscape Medical News
Category:   Articles > Pathology and Lab Medicine


2. MMP Inhibitor-Bearing Virus Active Against Solid Tumors
  An oncolytic herpes virus "armed" with matrix metalloproteinase (MMP) inhibition may be effective for control of solid tumors, investigators report in the February 15th issue of Cancer Research. Reuters Health Information
Category:   Articles > Pathology and Lab Medicine


3. Reduced-Intensity Conditioning Safe With Stem Cell Transplant in CML
  A reduction in intensity of the conditioning regimen prior to hematopoietic stem cell transplantation does not significantly reduce overall survival and allows adequate disease control in chronic myelogenous leukemia (CML), researchers report in the November 1st issue of Blood. Reuters Health Information
Category:   Articles > Pathology and Lab Medicine


4. ASCO 2009: New Oncotype DX Assay Predicts Risk for Recurrence in Stage 2 Colon Cancer
  A new genomic test, similar to the Oncotype DX test already used in breast cancer, can predict the risk for recurrence in stage 2 colon cancer, and thus identify patients who are more likely to benefit from adjuvant chemotherapy. Medscape Medical News
Category:   Articles > Pathology and Lab Medicine


5. Thromboembolism Prophylaxis Moot in Stem Cell Patients
  Venous thromboembolism (VTE) prevention efforts may be inappropriate in many patients undergoing hematopoietic stem cell transplantation (HSCT), according to researchers. Reuters Health Information
Category:   Articles > Pathology and Lab Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS